Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gastl

Showing results (41-50 of 132) with videos related to

Pageof 14
Sort By:
Journal of Interferon Research|January 1, 1985
Effect of human recombinant alpha-2- and gamma-interferon on the growth of human cell lines from solid tumors and hematologic malignanciesH Denz, M Lechleitner, C Marth, et al.
Stroke|January 4, 2001
Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic strokeE Gunsilius, A L Petzer, G Stockhammer, et al.
Journal of Hematotherapy & Stem Cell Research|February 16, 2002
Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemiaB Brunner, E Gunsilius, P Schumacher, et al.
Lancet (London, England)|September 22, 1984
Cyclosporin blood levels do correlate with clinical complicationsE Irschik, H Tilg, D Niederwieser, et al.
Blood|February 1, 1990
Minimal interferon-alpha doses for hairy cell leukemiaG Gastl, W Aulitzky, H Tilg, et al.
Lancet (London, England)|May 22, 2001
Circulating endothelial cells after transplantationE Gunsilius, A L Petzer, H C Duba, et al.
Annals of Hematology|April 26, 2001
Candida ciferrii, a new fluconazole-resistant yeast causing systemic mycosis in immunocompromised patientsE Gunsilius, C Lass-Flörl, C M Kähler, et al.
Immunobiology|July 1, 1986
Macrophage infiltration in non-Hodgkin's lymphomas: a quantitative in situ studyM Lechleitner, C Gattringer, G Gastl, et al.
Oncology|May 1, 1997
Angiogenesis as a target for tumor treatmentG Gastl, T Hermann, M Steurer, et al.
Leukemia Research|January 1, 1990
Recombinant interferon-alpha-2C in chronic myelogenous leukaemia: relationship of sensitivity of committed haematopoietic precursor cells in vitro (BFU-E, CFU-GM, CFU-Meg) and clinical responseD Geissler, G Gastl, W Aulitzky, et al.
Pageof 14

Showing results (41-50 of 132) with videos related to

Sort By:
Pageof 14
Journal of Interferon Research|January 1, 1985
Effect of human recombinant alpha-2- and gamma-interferon on the growth of human cell lines from solid tumors and hematologic malignanciesH Denz, M Lechleitner, C Marth, et al.
Stroke|January 4, 2001
Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic strokeE Gunsilius, A L Petzer, G Stockhammer, et al.
Journal of Hematotherapy & Stem Cell Research|February 16, 2002
Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemiaB Brunner, E Gunsilius, P Schumacher, et al.
Lancet (London, England)|September 22, 1984
Cyclosporin blood levels do correlate with clinical complicationsE Irschik, H Tilg, D Niederwieser, et al.
Blood|February 1, 1990
Minimal interferon-alpha doses for hairy cell leukemiaG Gastl, W Aulitzky, H Tilg, et al.
Lancet (London, England)|May 22, 2001
Circulating endothelial cells after transplantationE Gunsilius, A L Petzer, H C Duba, et al.
Annals of Hematology|April 26, 2001
Candida ciferrii, a new fluconazole-resistant yeast causing systemic mycosis in immunocompromised patientsE Gunsilius, C Lass-Flörl, C M Kähler, et al.
Immunobiology|July 1, 1986
Macrophage infiltration in non-Hodgkin's lymphomas: a quantitative in situ studyM Lechleitner, C Gattringer, G Gastl, et al.
Oncology|May 1, 1997
Angiogenesis as a target for tumor treatmentG Gastl, T Hermann, M Steurer, et al.
Leukemia Research|January 1, 1990
Recombinant interferon-alpha-2C in chronic myelogenous leukaemia: relationship of sensitivity of committed haematopoietic precursor cells in vitro (BFU-E, CFU-GM, CFU-Meg) and clinical responseD Geissler, G Gastl, W Aulitzky, et al.
Pageof 14